Study is first to find significant link between sleepiness and vitamin D
A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.
Dec 14, 2012
1
0
A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.
Dec 14, 2012
1
0
If your neighborhood is well-lit at night, you may not be sleeping well, according to a study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 ...
Mar 1, 2016
0
2
Although several medications are approved to treat attention-deficit/hyperactivity disorder (ADHD), some individuals experience limited benefits from the drugs or develop side effects from their use.
Oct 9, 2023
0
17
A team of American and British scientists have for the first time discovered genetic connections between sleep disturbance and a range of medical disorders including obesity.
Dec 19, 2016
0
252
People with the inherited disorder myotonic dystrophy (DM) often experience excessive daytime sleepiness and fatigue, as well as altered responses to anesthetics that can put them at risk for complications when hospitalized.
Sep 29, 2022
0
16
Concussions can increase the long-term risk of a wide range of sleep disorders, a new study indicates.
Mar 4, 2021
0
2
Patients and medical providers should be aware that chronic opioid use can interfere with sleep by reducing sleep efficiency and increasing the risk of sleep-disordered breathing, according to a position statement from the ...
Nov 19, 2019
0
3
A new study appearing in the journal CHEST may change the way we think about sleep disorders. In this study led by Dr. Luciano F. Drager, obstructive sleep apnea (OSA) and short sleep duration (SSD) were compared with excessive ...
Apr 1, 2019
0
3
Including genetic markers in addition to well known risk factors improves tests to predict Parkinson's disease, according to a study led by Queen Mary University of London.
Sep 16, 2020
0
4
The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken once ...
May 5, 2023
0
3